Open AccessSafety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results
Author(s) -
Farid Boulad,
Tsiporah B. Shore,
Koen van Besien,
Caterina P. Minniti,
Mihaela Barbu-Stevanovic,
Sylvie Wiener Fedus,
Fabiana Perna,
Jacques A. Greenberg,
Danielle Guarneri,
Vijay Nandi,
Audrey Mauguen,
Karina Yazdanbakhsh,
Michel Sadelain,
Patricia Shi
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.199414
Subject(s) - plerixafor , interim , mobilization , progenitor cell , medicine , cd34 , oncology , stem cell , cxcr4 , biology , political science , chemokine , law , genetics , receptor